Product
Toripalimab plus Lenvatinib
1 clinical trial
1 indication
Indication
Hepatocellular CarcinomaClinical trial
Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma: a Single-center, Single-arm, Non-randomized Clinical StudyStatus: Recruiting, Estimated PCD: 2024-04-01